Methyl 5-tert-butylisoxazole-3-carboxylate, 95.0%, 1g

Diethylenetriamine, min. 98%, for synthesis, 100 ml, glass packaging

4-(5-Fluoro-1,3-dioxo-1,3-dihydro-isoindol-2-yl)-benzoic acid, 1g

8-Bromo-4-methoxyquinoline-2-carboxylic acid, 97.0%, 1g

Ethyl thiooxamate, 98.0%, 25g

5-(4-Fluorophenyl)-2-methyl-4-(4-pyridyl)-1h-pyrimidin-6-one, 98%, 500mg

(R)-1-(perfluorophenyl)ethan-1-ol, 95%, 250mg

2,3,4,6,7,8-Hexahydro-1H-pyrimido[1,2-a]pyrimidine, 95.0%, 10g

(3-((2-Methoxyethyl)carbamoyl)phenyl)boronic acid, 97%, 100mg

((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl 4-methylbenzenesulfonate, 97%, 1g

5-Bromo-2-methoxyisonicotinaldehyde, 95.0%, 100g

2,2-Dimethyl-3-oxopentanal, 95.0%, 250mg

4'-Methoxy-2'-methylacetophenone, 97.0%, 100mg